$AMPX
Amprius Technologies, Inc.

2023 Q4 Form 10-Q Financial Statement

#000189928723000117 Filed on November 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $3.944M $2.798M
YoY Change 397.98% 242.89%
Cost Of Revenue $7.823M $7.046M
YoY Change 225.96% 208.49%
Gross Profit -$3.879M -$4.248M
YoY Change 141.23% 189.37%
Gross Profit Margin -98.35% -151.82%
Selling, General & Admin $4.575M $4.068M
YoY Change 5.2% 71.86%
% of Gross Profit
Research & Development $1.290M $815.0K
YoY Change 86.96% 67.01%
% of Gross Profit
Depreciation & Amortization $488.0K $400.0K
YoY Change 15.37% 3.63%
% of Gross Profit
Operating Expenses $5.865M $4.883M
YoY Change 16.39% 71.03%
Operating Profit -$9.744M -$9.131M
YoY Change 46.59% 111.22%
Interest Expense $591.0K $640.0K
YoY Change 0.0% 710.13%
% of Operating Profit
Other Income/Expense, Net -$581.0K $639.0K
YoY Change 708.86%
Pretax Income -$9.734M -$8.490M
YoY Change 60.73% 100.05%
Income Tax
% Of Pretax Income
Net Earnings -$9.734M -$8.500M
YoY Change 60.73% 100.28%
Net Earnings / Revenue -246.81% -303.79%
Basic Earnings Per Share -$0.10
Diluted Earnings Per Share -$0.11 -$0.10
COMMON SHARES
Basic Shares Outstanding 88.40M shares 86.27M shares
Diluted Shares Outstanding 86.35M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $45.76M $53.40M
YoY Change -34.34% -27.65%
Cash & Equivalents $45.80M $53.40M
Short-Term Investments
Other Short-Term Assets $2.766M $5.630M
YoY Change -35.54% 106.15%
Inventory $730.0K $487.0K
Prepaid Expenses
Receivables $1.265M $1.900M
Other Receivables $0.00 $0.00
Total Short-Term Assets $50.52M $61.39M
YoY Change -32.79% -21.11%
LONG-TERM ASSETS
Property, Plant & Equipment $56.91M $16.67M
YoY Change 1243.46% 336.01%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $305.0K $957.0K
YoY Change -52.64% 58.44%
Total Long-Term Assets $57.21M $25.22M
YoY Change 615.35% 190.46%
TOTAL ASSETS
Total Short-Term Assets $50.52M $61.39M
Total Long-Term Assets $57.21M $25.22M
Total Assets $107.7M $86.62M
YoY Change 29.54% 0.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.341M $3.578M
YoY Change 225.0% 35.48%
Accrued Expenses $6.682M $5.649M
YoY Change 146.75% 158.77%
Deferred Revenue $3.434M $3.569M
YoY Change 29.1% 348.93%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $13.46M $13.88M
YoY Change 94.55% 126.12%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $34.48M $6.980M
YoY Change 970.44% 59.95%
Total Long-Term Liabilities $34.48M $6.980M
YoY Change 970.44% 59.95%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.46M $13.88M
Total Long-Term Liabilities $34.48M $6.980M
Total Liabilities $47.94M $20.86M
YoY Change 372.83% 98.66%
SHAREHOLDERS EQUITY
Retained Earnings -$129.7M -$119.9M
YoY Change 39.61% 38.08%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $59.80M $65.76M
YoY Change
Total Liabilities & Shareholders Equity $107.7M $86.62M
YoY Change 29.54% 0.13%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$9.734M -$8.500M
YoY Change 60.73% 100.28%
Depreciation, Depletion And Amortization $488.0K $400.0K
YoY Change 15.37% 3.63%
Cash From Operating Activities -$4.800M -$8.670M
YoY Change -15.76% 222.07%
INVESTING ACTIVITIES
Capital Expenditures $5.751M $8.930M
YoY Change 683.51% 1514.83%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$5.751M -$8.930M
YoY Change 683.51% 1514.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.916M 5.990M
YoY Change 42.38% -91.66%
NET CHANGE
Cash From Operating Activities -4.800M -8.670M
Cash From Investing Activities -5.751M -8.930M
Cash From Financing Activities 2.916M 5.990M
Net Change In Cash -7.635M -11.61M
YoY Change 74.16% -116.93%
FREE CASH FLOW
Cash From Operating Activities -$4.800M -$8.670M
Capital Expenditures $5.751M $8.930M
Free Cash Flow -$10.55M -$17.60M
YoY Change 64.04% 442.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4068000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
957000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
644000 usd
CY2023Q3 us-gaap Assets
Assets
86615000 usd
CY2022Q4 us-gaap Assets
Assets
83171000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3578000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1028000 usd
CY2023Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
5649000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2708000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3569000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2660000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1079000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
521000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
13875000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6917000 usd
CY2023Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
117000 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
720000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6867000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2501000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
20859000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
10138000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 usd
CY2022Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87642244 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
84610114 shares
CY2023Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
9000 usd
CY2022Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
8000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
185676000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
165912000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-119929000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-92887000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
65756000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
73033000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
86615000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
83171000 usd
CY2023Q3 us-gaap Revenues
Revenues
2798000 usd
CY2022Q3 us-gaap Revenues
Revenues
816000 usd
us-gaap Revenues
Revenues
5109000 usd
us-gaap Revenues
Revenues
3617000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
7046000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
2326000 usd
us-gaap Cost Of Revenue
CostOfRevenue
15906000 usd
us-gaap Cost Of Revenue
CostOfRevenue
7592000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
-4248000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
-1510000 usd
us-gaap Gross Profit
GrossProfit
-10797000 usd
us-gaap Gross Profit
GrossProfit
-3975000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
815000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
490000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2387000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6080000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
2813000 usd
us-gaap Operating Expenses
OperatingExpenses
18168000 usd
us-gaap Operating Expenses
OperatingExpenses
7419000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9131000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4323000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-28965000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-11394000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
79000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1923000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-4244000 usd
us-gaap Net Income Loss
NetIncomeLoss
-27042000 usd
us-gaap Net Income Loss
NetIncomeLoss
-11276000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85411590 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85411590 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
66858720 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66858720 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.32
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.32
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
73033000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2376000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
726000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-9102000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
67035000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8177000 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2021 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201602Member
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P4Y
CY2023Q3 us-gaap Deferred Costs
DeferredCosts
0 usd
CY2022Q4 us-gaap Deferred Costs
DeferredCosts
367000 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87642244 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
84610114 shares
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
118000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-8492000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86354067 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
86354067 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6331000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
112000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1115000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-8492000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
65756000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
13858000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8000 usd
CY2022Q1 ampx Adjustments To Additional Paid In Capital Capital Contributions From Parent
AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent
247000 usd
CY2022Q2 ampx Adjustments To Additional Paid In Capital Capital Contributions From Parent
AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent
258000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
890000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-4154000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
8531000 usd
CY2022Q3 ampx Stock Issued During Period Value Business Combination And Pipe Investment
StockIssuedDuringPeriodValueBusinessCombinationAndPIPEInvestment
70938000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
777000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-4244000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
76002000 usd
us-gaap Net Income Loss
NetIncomeLoss
-11276000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2765000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2123000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1318000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1140000 usd
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
1070000 usd
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
1585000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
811000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
417000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1201000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
520000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-13000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3000 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
1692000 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
1512000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-101000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2206000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
9000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1226000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2275000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2308000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
425000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
306000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-282000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-727000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-350000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20753000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8184000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11799000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
747000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11799000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-747000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
16542000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
406000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
25000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
115000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
ampx Proceeds From Issuance Of Common Sock In Connection With Business Combination And Pipe Investment
ProceedsFromIssuanceOfCommonSockInConnectionWithBusinessCombinationAndPIPEInvestment
0 usd
ampx Proceeds From Issuance Of Common Sock In Connection With Business Combination And Pipe Investment
ProceedsFromIssuanceOfCommonSockInConnectionWithBusinessCombinationAndPIPEInvestment
77884000 usd
ampx Payment Of Transaction And Issuance Costs In Connection With Business Combination And Pipe Investment
PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment
0 usd
ampx Payment Of Transaction And Issuance Costs In Connection With Business Combination And Pipe Investment
PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment
6794000 usd
us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
0 usd
us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
505000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16252000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
71578000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16300000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
62647000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
69752000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11489000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
53452000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74136000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53396000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
73803000 usd
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
56000 usd
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
333000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
53452000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74136000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-8500000 usd
us-gaap Net Income Loss
NetIncomeLoss
-27000000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-119900000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53400000 usd
CY2023Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
-17000000 usd
CY2023Q2 ampx Project Grant Value
ProjectGrantValue
50000000 usd
CY2022Q3 ampx Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
1.45590
ampx Number Of Executive Employees Of Parent Sharing Facilities Costs
NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts
2 executiveemployee
ampx Number Of Executive Employees Of Parent Sharing Facilities Costs
NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts
2 executiveemployee
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
ReclassificationCertain accounts in the prior period condensed consolidated statements of operations were reclassified to conform with the current period presentation. The reclassification had no impact on our consolidated balance sheet, net loss and cash flows in those periods.
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances; the results of which form the basis for making judgements that are not readily apparent from other sources. Actual results could materially differ from management estimates using different assumptions or under different conditions. </span></div>Our significant accounting estimates include useful lives of property, plant and equipment; valuation of deferred taxes; lower of cost or net realizable adjustment of inventory; carve-out of financial statements including the allocation of assets, liabilities and expenses prior to the Business Combination; incremental borrowing rate used in calculating lease obligations and right-of-use assets; and fair value of common stock prior to the Business Combination and other inputs used to value stock-based compensation awards.
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
56000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
56000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentration of Credit RiskAccounts receivable mainly consist of amounts due from U.S. government agencies or sponsored entities and large public entities which limits our credit risk. Through September 30, 2023, we have not experienced any credit losses.
CY2023Q3 us-gaap Revenues
Revenues
2798000 usd
CY2022Q3 us-gaap Revenues
Revenues
816000 usd
us-gaap Revenues
Revenues
5109000 usd
us-gaap Revenues
Revenues
3617000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1900000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
700000 usd
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
300000 usd
CY2023Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3700000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3400000 usd
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2900000 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
400000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
900000 usd
CY2022Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
200000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1700000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
11300000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
8300000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3000000 usd
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
89000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
180000 usd
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
142000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
218000 usd
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
256000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
102000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
487000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
500000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25235000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11480000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8562000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7244000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16673000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4236000 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
400000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1300000 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
400000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1100000 usd
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2344000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
481000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2122000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1840000 usd
CY2023Q3 ampx Accrued Purchases Of Property And Equipment
AccruedPurchasesOfPropertyAndEquipment
576000 usd
CY2022Q4 ampx Accrued Purchases Of Property And Equipment
AccruedPurchasesOfPropertyAndEquipment
0 usd
CY2023Q3 ampx Accrued Offering Costs Current
AccruedOfferingCostsCurrent
251000 usd
CY2022Q4 ampx Accrued Offering Costs Current
AccruedOfferingCostsCurrent
194000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
356000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
193000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5649000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2708000 usd
CY2023Q3 ampx Shares Authorized
SharesAuthorized
1000000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
6300000 usd
CY2023Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
47720736 shares
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1115000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
777000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2765000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2123000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2023Q3 ampx Lessee Finance Lease Number Of Leases
LesseeFinanceLeaseNumberOfLeases
0 lease
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y9M18D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.079
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5200000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
700000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
400000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
304000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
152000 usd
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
79000 usd
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
27000 usd
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
20000 usd
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
16000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
403000 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
195000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
274000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1126000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1158000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1193000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1241000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1278000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
4729000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
10999000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3053000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
7946000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8492000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-8492000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4244000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-4244000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-27042000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-27042000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-11276000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11276000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86354067 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
86354067 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69013168 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69013168 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85411590 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85411590 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
66858720 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66858720 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.32
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.32
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
61722315 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
62151131 shares

Files In Submission

Name View Source Status
ampx-20230930_cal.xml Edgar Link unprocessable
ampx-20230930_def.xml Edgar Link unprocessable
0001899287-23-000117-index-headers.html Edgar Link pending
0001899287-23-000117-index.html Edgar Link pending
0001899287-23-000117.txt Edgar Link pending
0001899287-23-000117-xbrl.zip Edgar Link pending
ampx-20230930.htm Edgar Link pending
ampx-20230930.xsd Edgar Link pending
ampx-20230930xexhibit311.htm Edgar Link pending
ampx-20230930xexhibit312.htm Edgar Link pending
ampx-20230930xexhibit321.htm Edgar Link pending
ampx-20230930xexhibit322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
ampx-20230930_lab.xml Edgar Link unprocessable
ampx-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ampx-20230930_htm.xml Edgar Link completed
report.css Edgar Link pending
Show.js Edgar Link pending